Marc E. Lippman, Director at SEATTLE GENETICS INC /WA (SGEN), sold 7,400 shares at $69.25 ($512K) on 2018-07-31, disclosed to the SEC on 2018-08-02.
Open-market sale of $512k SGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SGEN | SELL | 2019-11-20 | $6.1M | — | Filing → |
| SGEN | SELL | 2017-11-17 | $174K | — | Filing → |
| SGEN | SELL | 2016-11-09 | $58K | — | Filing → |